000 01159 a2200325 4500
005 20250515062053.0
264 0 _c20070405
008 200704s 0 0 eng d
022 _a1744-7666
024 7 _a10.1517/14656566.8.5.657
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSamanta, Johan
245 0 0 _aDuodenal levodopa infusion for the treatment of Parkinson's disease.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cApr 2007
300 _a657-64 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aAntiparkinson Agents
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aInfusions, Parenteral
650 0 4 _aIntestinal Absorption
650 0 4 _aLevodopa
_xadministration & dosage
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aQuality of Life
700 1 _aHauser, Robert A
773 0 _tExpert opinion on pharmacotherapy
_gvol. 8
_gno. 5
_gp. 657-64
856 4 0 _uhttps://doi.org/10.1517/14656566.8.5.657
_zAvailable from publisher's website
999 _c16930839
_d16930839